GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
5,004
Funds Holding Change
+7
Funds Holding Growth
+0.1%
Value
$1.38T
Holding in Top 10
863
Top 10 Change
-100
Top 10 Growth
-10%
Value Growth
-1%
New
203
Increased
2,276
Reduced
2,138
Closed
142
Capital Inflow
$34.5B
Capital Outflow
$38.1B
Net Capital Flow
-$3.6B
Capital Flow Change
-$12.2B
Calls
$21.5B
Puts
$24.1B
Net Calls
-$2.61B
Put/Call Ratio
1.12